| Sources | Names Used |
|---|---|
| CTRPv2 | BRD-K66532283 |
| PharmacoGx | BRD-K66532283 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CD59 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.01 |
| mRNA | WHAMM | CTRPv2 | pan-cancer | AAC | -0.083 | 0.01 |
| mRNA | ZSCAN23 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.01 |
| mRNA | IL21R | CTRPv2 | pan-cancer | AAC | -0.089 | 0.01 |
| mRNA | RBM15B | CTRPv2 | pan-cancer | AAC | 0.088 | 0.01 |
| mRNA | LMAN2 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.01 |
| mRNA | RP11-457D20.2 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.01 |
| mRNA | TIGD3 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.01 |
| mRNA | USP11 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.01 |
| mRNA | ZNF549 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.01 |
